KV Unit Ethex To Pay $28M In Oversize Pill Case

Law360, New York (March 3, 2010, 6:55 PM EST) -- KV Pharmaceutical Co. unit Ethex Corp. has pled guilty to charges that it neglected to alert the U.S. Food and Drug Administration of oversize tablets of an attention deficit disorder drug and a heart medication due to manufacturing problems, agreeing to cough up $27.6 million.

On Tuesday in the U.S. District Court for the Eastern District of Missouri, Ethex pled guilty to two felony counts of failing to file field alerts with the FDA in connection with oversize tablets of heart drug propafenone and ADD drug...
To view the full article, register now.